These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23388371)

  • 1. Seasonal influenza and Tdap vaccination policies in Michigan hospitals: progress yet substantial capacity to improve.
    Carlton CA; Sienko DG; Vranesich PA
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):321-4. PubMed ID: 23388371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time.
    Weber DJ; Consoli SA; Sickbert-Bennett E; Rutala WA
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):81-3. PubMed ID: 22173527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and acceptance of a health care-based mandatory vaccination program.
    Leibu R; Maslow J
    J Occup Environ Med; 2015 Jan; 57(1):58-61. PubMed ID: 25563540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mandatory campaign to vaccinate health care workers against pertussis.
    Esolen LM; Kilheeney KL
    Am J Infect Control; 2013 Aug; 41(8):740-2. PubMed ID: 23394887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tdap vaccine: current indications for adolescent and adult patients in the United States.
    Kirchner JT
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S7-9. PubMed ID: 22086895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy.
    Fortner KB; Kuller JA; Rhee EJ; Edwards KM
    Obstet Gynecol Surv; 2012 Apr; 67(4):251-7. PubMed ID: 22495061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population.
    Tseng HF; Sy LS; Qian L; Marcy SM; Jackson LA; Glanz J; Nordin J; Baxter R; Naleway A; Donahue J; Weintraub E; Jacobsen SJ;
    Clin Infect Dis; 2013 Feb; 56(3):315-21. PubMed ID: 23196953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
    Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.
    Hanson MP; Kwan-Gett TS; Baer A; Rietberg K; Ohrt M; Duchin JS
    Arch Pediatr Adolesc Med; 2011 Jul; 165(7):647-52. PubMed ID: 21727277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.
    Mills B; Fensterheim L; Taitel M; Cannon A
    Vaccine; 2014 Jan; 32(4):521-5. PubMed ID: 24269619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.